齐拉西酮
奎硫平
奥氮平
利培酮
奋乃静
医学
中止
抗精神病药
内科学
非定型抗精神病薬
氯氮平
精神分裂症(面向对象编程)
精神科
麻醉
药理学
作者
Jeffrey A. Lieberman,T. Scott Stroup,Joseph P. McEvoy,Marvin S. Swartz,Robert A. Rosenheck,Diana O. Perkins,Richard S.E. Keefe,Sonia M. Davis,C.E. Davis,Barry D. Lebowitz,Joanne B. Severe,John Hsiao
摘要
The majority of patients in each group discontinued their assigned treatment owing to inefficacy or intolerable side effects or for other reasons. Olanzapine was the most effective in terms of the rates of discontinuation, and the efficacy of the conventional antipsychotic agent perphenazine appeared similar to that of quetiapine, risperidone, and ziprasidone. Olanzapine was associated with greater weight gain and increases in measures of glucose and lipid metabolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI